Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises
source: Pediatric Emergency Care
year: 2019
authors: Hagedorn JM, Monico EC
summary/abstract:OBJECTIVES:
Sickle cell disease is the most common hemoglobin variant in the world and can present with recurrent vaso-occlusive painful crises. Pain control in these patients is often difficult and requires a multimodal approach. In patients with uncontrolled pain after traditional pain control methods, ketamine infusions have proven beneficial. Unfortunately, no source alone had described ketamine infusions for pediatric sickle cell patients. Our objective was to provide a thorough definitive reference for health care providers regarding the use of ketamine infusion for pain control in pediatric sickle cell painful crises.
METHODS:
Literature review.
RESULTS:
Low-dose ketamine infusions for pediatric patients with sickle cell disease painful crises resulted in improved pain scores and reduced opioid usage.
CONCLUSIONS:
Ketamine infusions have shown promise in assisting physicians in appropriately treating pediatric sickle cell painful crises.
DOI: 10.1097/PEC.0000000000000978
read more full text
+myBinderRelated Content
-
Bioverativ and Sangamo announce FDA acceptance of IND application for gene-edited cell therapy BIVV003 to treat sick...Bioverativ Inc., a Sanofi company dedi...
-
Ron Brathwaite, MDDr. Brathwaite graduated from the Univer...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
2019 Cure Sickle Cell Initiative Annual Forum: Accelerating Scientific PrioritiesTuesday, November 19 - Thursday, Novembe...
-
The effects of music therapy on transition outcomes in adolescents and young adults with sickle cell diseaseBackground: The Build, Educate, Advance...
-
University of Pittsburgh Medical CenterPeople with inherited blood disorders re...
-
Guidelines on Red Cell Transfusion in Sickle Cell Disease. Part I: Principles and Laboratory AspectsBlood transfusion in the management of s...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.